Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, Mohd. Iqbal Yatoo et al.
Newly emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are continuously posing high global public health concerns and panic resulting in waves of coronavirus disease 2019 (COVID-19) pandemic. Depending on the extent of genomic variations, mutations and adaptation, fe...
Harapan Harapan, Youdiil Ophinni, Dewi Megawati, Andri Frediansyah et al.
The 2022 multi-country monkeypox outbreak in humans has brought new public health adversity on top of the ongoing coronavirus disease 2019 (COVID-19) pandemic. The disease has spread to 104 countries throughout six continents of the world, with the highest burden in North America and Europe. The eti...
Endang Mutiawati, Marhami Fahriani, Sukamto S. Mamada, Jonny Karunia Fajar et al.
<ns4:p> <ns4:bold>Background</ns4:bold> : The present study aimed to determine the global prevalence of anosmia and dysgeusia in coronavirus disease 2019 (COVID-19) patients and to assess their association with severity and mortality of COVID-19. Moreover, this study aimed to discuss the possible pa...
Sri Masyeni, Muhammad Iqhrammullah, Andri Frediansyah, Firzan Nainu et al.
Broad-spectrum antiviral agents targeting viral RNA-dependent RNA polymerase (RdRp) are expected to be a key therapeutic strategy in the ongoing coronavirus disease 2019 (COVID-19) pandemic and its future variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes...
Firzan Nainu, Rufika S. Abidin, Muh. Akbar Bahar, Andri Frediansyah et al.
Coronavirus disease 2019 (COVID-19) pandemic continues to constitute a public health emergency of international concern. Multiple vaccine candidates for COVID-19, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have entered clinical trials. However, some evidence sug...
Syahrul Syahrul, Helnida Anggun Maliga, Muhammad Ilmawan, Marhami Fahriani et al.
<ns4:p> <ns4:bold>Background</ns4:bold> : In this study, we aimed to determine the global prevalence, chronological order of symptom appearance, and mortality rates with regard to hemorrhagic and ischemic stroke in patients with coronavirus disease 2019 (COVID-19) and to discuss possible pathogenese...
Fauzi Yusuf, Marhami Fahriani, Sukamto S. Mamada, Andri Frediansyah et al.
<ns4:p> <ns4:bold>Background:</ns4:bold> This study aimed to determine the cumulative prevalence of prolonged gastrointestinal (GI) symptoms, including nausea, vomiting, diarrhea, lack of appetite, abdominal pain, and dysgeusia, in survivors of both mild and severe COVID-19 worldwide and to discuss ...
Firzan Nainu, Andri Frediansyah, Sukamto S. Mamada, Andi Dian Permana et al.
experimental models prior to clinical studies has promoted numerous biomedical breakthroughs, including in the discovery and development of drug candidates to treat metabolic disorders. Indeed, chemicals isolated from natural products have been extensively studied as prospective drug candidates to m...
Sukamto S. Mamada, Firzan Nainu, Ayu Masyita, Andri Frediansyah et al.
Tuberculosis has become a major health problem globally. This is worsened by the emergence of resistant strains of Mycobacterium tuberculosis showing ability to evade the effectiveness of the current antimycobacterial therapies. Therefore, the efforts carried out to explore new entities from many so...
Andri Frediansyah, Malik Sallam, Amanda Yufika, Khan Sharun et al.
The emergence of acute, severe non hepA-E hepatitis of unknown etiology (ASHUE) has attracted global concern owing to the very young age of the patients and its unknown etiology. Although this condition has been linked to several possible causes, including viral infection, drugs and/or toxin exposur...
Firzan Nainu, Andri Frediansyah, Emil Salim, Deepak Chandran et al.
Nainu, Firzan; Frediansyah, Andri; Salim, Emil; Chandran, Deepak; Dhama, Kuldeep; Rabaan, Ali A.; Harapan, Harapan; Emran, Talha Bin Author Information